Assessment of L-Arginine supplementation on insulin resistanc, sugar and lipid profile

Phase 3

• Conditions: Diabetes.; Non-insulin-dependent diabetes mellitus

• Registration Number: IRCT2012071010240N1
• Lead Sponsor: Vice chancellor for Research, Yazd University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

Criteria for inclusion in the study: Suffering from diabetes type 2? Diabetes record between 4-10 years. Fasting glucose range of 160-400 mg/dl. Aged between 30 to 60.
Criteria for exclusion from the study: Suffering from Renal, Liver; Parathyroid and GI Diseases. Pregnancy and lactation. Use of insulin; HbA1c<7mg/dl

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HbA1c. Timepoint: at the begining of the study and 3 month after intervention. Method of measurement: Enzyme colorimetry.;Insulin. Timepoint: at the begining of the study and 3 month after intervention. Method of measurement: Insulin kit.;Fasting blood sugar. Timepoint: at the begining of the study and 3 month after intervention. Method of measurement: Autoanalaizer.;HDL. Timepoint: at the begining of the study and 3 month after intervention. Method of measurement: Enzyme colorimetry.;LDL. Timepoint: at the begining of the study and 3 month after intervention. Method of measurement: Enzyme colorimetry.;TG. Timepoint: at the begining of the study and 3 month after intervention. Method of measurement: Enzyme colorimetry.;Cholesterol. Timepoint: at the begining of the study and 3 month after intervention. Method of measurement: Enzyme colorimetry.

Secondary Outcome Measures

Name	Time	Method
Anthropometric indicators: weight, height, body mass index, waist circumference. Timepoint: at the begining of the study and 3 month after intervention. Method of measurement: Tape and scale.;Insulin Resistance. Timepoint: at the begining of the study and 3 month after intervention. Method of measurement: HOMA index.;Insulin Sensitivity. Timepoint: at the begining of the study and 3 month after intervention. Method of measurement: HOMA2 calculator software.;Beta cell function. Timepoint: at the begining of the study and 3 month after intervention. Method of measurement: HOMA2 calculator software.